My Treatment Approach to Giant Cell Arteritis

Giant cell arteritis (GCA) is the most common primary systemic vasculitis in adults 50 years or older. Expanded use of advanced arterial imaging has assisted both in the diagnosis of GCA and recognition of disease subsets. Although glucocorticoids have been the mainstay of treatment for almost 7 decades, new therapeutic options have emerged. This review aims to provide the clinician with a pragmatic approach to evaluating and managing patients with GCA while also addressing recent diagnostic and therapeutic developments. (C) 2021 Mayo Foundation for Medical Education and Research

Automated summary

Giant cell arteritis (GCA) is the most common primary systemic vasculitis in adults over 50 years old, and advances in arterial imaging have improved diagnosis and disease subset recognition. While glucocorticoids have been the main treatment for decades, new therapeutic options have emerged, providing clinicians with more choices for managing GCA patients.